4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # 4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union ##### Up next ![Material Intelligence in Motion: Engineering the Future of Adaptive Apparel at Functional Fabric Fair Spring 2026](https://i0.wp.com/mma.prnasia.com/media2/2945480/photo_1.jpg?resize=200%2C110&ssl=1 "Material Intelligence in Motion: Engineering the Future of Adaptive Apparel at Functional Fabric Fair Spring 2026") [](https://thailandbusinessnews.net/press-release/material-intelligence-in-motion-engineering-the-future-of-adaptive-apparel-at-functional-fabric-fair-spring-2026/) ###### [Material Intelligence in Motion: Engineering the Future of Adaptive Apparel at Functional Fabric Fair Spring 2026](https://thailandbusinessnews.net/press-release/material-intelligence-in-motion-engineering-the-future-of-adaptive-apparel-at-functional-fabric-fair-spring-2026/) Published on 31 March 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/2730645/5888947/4DMedical_Logo.jpg?p=medium600 "logo") ***In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion.*** MELBOURNE, Australia, March 31, 2026 /PRNewswire/ — 4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has received CE Mark certification for commercial use in the European Union. 4DMedical will quickly launch commercial deployment of CT:VQ across one of the world’s largest respiratory imaging markets. [![4DMedical’s CT:VQ™ technology combines the anatomical clarity of CT with functional ventilation-perfusion mapping from routine non-contrast CT scans, giving clinicians quantitative insights into regional lung function without radiotracers.](https://mma.prnasia.com/media2/2944827/Lungs_Graphic_Cutouts_Color_BW.jpg?p=medium600 "4DMedical’s CT:VQ™ technology combines the anatomical clarity of CT with functional ventilation-perfusion mapping from routine non-contrast CT scans, giving clinicians quantitative insights into regional lung function without radiotracers.")](https://mma.prnasia.com/media2/2944827/Lungs_Graphic_Cutouts_Color_BW.jpg?p=medium600) 4DMedical’s CT:VQ™ technology combines the anatomical clarity of CT with functional ventilation-perfusion mapping from routine non-contrast CT scans, giving clinicians quantitative insights into regional lung function without radiotracers. In a separate but concurrent announcement, 4DMedical has secured firm commitments from select institutional investors for an AU$83 million single-tranche private placement. This additional capital will support the Company’s growth strategy, particularly the expansion of CT:VQ™ in Europe. CT:VQ™ is the world’s first and only non-contrast, ventilation-perfusion imaging technology, providing quantitative functional lung insights from routine non-contrast CT scans without the need for radiotracers or specialised nuclear medicine infrastructure. Pulmonary disease is fundamentally functional—defined by abnormalities in ventilation and perfusion—yet most routine imaging available to radiologists and pulmonologists remains purely structural. CT:VQ™ bridges that gap by generating ventilation and perfusion maps allowing clinicians to visualize regional lung function with the anatomical clarity of CT. For large medical institutions, CT:VQ™ is designed to fit within existing CT-based workflows and infrastructure. CT:VQ offers relief from long-standing constraints associated with conventional nuclear VQ imaging, including radiotracer availability, workforce limitations and operational complexity. The European market represents a significant opportunity for advanced cardiothoracic imaging. With a population of more than 450 million, a highly developed hospital-based imaging infrastructure and an extensive installed base of CT scanners, the EU is well positioned for adoption of CT-based functional lung imaging. 4DMedical estimates that approximately 400,000 nuclear VQ scans are performed annually across the EU, underscoring the scale of clinical need. "CE Mark certification for CT:VQ™ is a significant milestone that opens access to one of the world’s largest and most sophisticated healthcare markets," said Andreas Fouras, Managing Director, CEO and Founder of 4DMedical. "Combined with FDA clearance, 4DMedical now has regulatory clearance to rapidly commercialise CT:VQ™ across both the U.S. and the EU. "The clinical need for CT:VQ™ is universal. The limitations of nuclear VQ scanning—radiotracer constraints, limited access and operational complexity—exist across healthcare systems globally. Europe has the clinical expertise, imaging infrastructure and research leadership to play a major role in the adoption and evidence generation for this technology." The CE Mark follows growing U.S. momentum for CT:VQ™, which is now deployed at six leading academic medical centres: Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, University of Chicago Medicine, and the recently announced initial deployment at Mayo Clinic. 4DMedical believes this early adoption by major U.S. institutions demonstrates strong interest in CT:VQ™ among leading radiology and pulmonary teams and provides a blueprint for expansion into Europe. 4DMedical said it is now advancing plans to expand commercial engagement across Europe and to work with leading hospitals and clinicians on adoption, evaluation and research initiatives for CT:VQ™. **About CT:VQ™** CT:VQ™ is 4DMedical’s proprietary ventilation-perfusion imaging solution that generates functional lung information from non-contrast CT scans. Built on the Company’s patented XV Technology®, CT:VQ™ is designed to provide quantitative ventilation and perfusion insights within familiar CT workflows, without requiring radiotracers. **About 4DMedical** 4DMedical Limited (ASX:4DX) is a global medical technology company that creates and deploys the most advanced software-based cardiothoracic imaging technology—integrating both proprietary algorithms and artificial intelligence. 4DMedical’s software platform delivers deep, quantitative, insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. These insights help respiratory physicians, radiologists and hospital teams quantify regional lung function, support diagnosis and disease monitoring, and inform treatment and surgical planning. 4DMedical’s solutions are designed to integrate into existing clinical workflows. They provide actionable, patient-specific information that supports better decision-making and operational efficiency across a range of respiratory conditions. Learn more at [www.4dmedical.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4652192-1&h=2997271895&u=https%3A%2F%2Fwww.4dmedical.com%2F&a=www.4dmedical.com). Photo – [https://mma.prnasia.com/media2/2944827/Lungs\_Graphic\_Cutouts\_Color\_BW.jpg?p=medium600](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4652192-1&h=3556244766&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2944827%2FLungs_Graphic_Cutouts_Color_BW.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2944827%2FLungs_Graphic_Cutouts_Color_BW.jpg) Logo – [https://mma.prnasia.com/media2/2730645/5888947/4DMedical\_Logo.jpg?p=medium600](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4652192-1&h=1370161454&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2730645%2F5888947%2F4DMedical_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2730645%2F5888947%2F4DMedical_Logo.jpg) [Source link ](http://www.prnasia.com/story/archive/4921712_AE21712_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/addentax-invests-equity-stake-in-fresh-food-marketing-solution-provider-well-information-technology-corporation/) ## Addentax Invests Equity Stake in Fresh Food Marketing Solution Provider, Well Information Technology Corporation SHENZHEN, China, Jan. 13, 2025 /PRNewswire/ — Addentax Group Corp. ("Addentax" or… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - January 13, 2025 [](https://thailandbusinessnews.net/press-release/lunit-to-present-ai-analyzed-immune-phenotype-study-as-immunotherapy-response-predictor-for-advanced-gastric-cancer-at-esmo-congress-2024/) ![Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2024/09/Lunit_SCOPE_IO.jpg?resize=260%2C140&ssl=1 "Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024 Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - September 10, 2024 [](https://thailandbusinessnews.net/press-release/ancel-to-showcase-comprehensive-automotive-diagnostic-solutions-at-automechanika-shanghai-2025/) ![ANCEL to Showcase Comprehensive Automotive Diagnostic Solutions at Automechanika Shanghai 2025](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2025/11/ANCEL_s_themed_Professional_Auto_Service_Solutions_booth_Automechanika_Shanghai_2025.jpg?resize=260%2C140&ssl=1 "ANCEL to Showcase Comprehensive Automotive Diagnostic Solutions at Automechanika Shanghai 2025") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## ANCEL to Showcase Comprehensive Automotive Diagnostic Solutions at Automechanika Shanghai 2025 SHENZHEN, China, Nov. 21, 2025 /PRNewswire/ — ANCEL is set to present… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - November 21, 2025 ##### Most Read - [![DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dayone-launches-singapores-first-biological-data-center-prototype-with-cortical-labs-and-nus-medicine/ "DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine") [DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine](https://thailandbusinessnews.net/press-release/dayone-launches-singapores-first-biological-data-center-prototype-with-cortical-labs-and-nus-medicine/ "DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine") - [![Kelun-Biotech Announces 2026 Interim Results](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/kelun-biotech-announces-2026-interim-results/ "Kelun-Biotech Announces 2026 Interim Results") [Kelun-Biotech Announces 2026 Interim Results](https://thailandbusinessnews.net/press-release/kelun-biotech-announces-2026-interim-results/ "Kelun-Biotech Announces 2026 Interim Results") - [![Karjengon Wu's Unique Aesthetic Language: Taiwanese Jewelry Artist Shines on the Global Stage](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2025/08/image_800964_29339863.jpg?fit=599%2C580&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/karjengon-wus-unique-aesthetic-language-taiwanese-jewelry-artist-shines-on-the-global-stage/ "Karjengon Wu's Unique Aesthetic Language: Taiwanese Jewelry Artist Shines on the Global Stage") [Karjengon Wu's Unique Aesthetic Language: Taiwanese Jewelry Artist Shines on the Global Stage](https://thailandbusinessnews.net/press-release/karjengon-wus-unique-aesthetic-language-taiwanese-jewelry-artist-shines-on-the-global-stage/ "Karjengon Wu's Unique Aesthetic Language: Taiwanese Jewelry Artist Shines on the Global Stage") - [![Uzbekistan Sees Foreign Investment Growth of over 60 per cent in 2024](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2025/06/MIIT_Uzbekistan.jpg?fit=599%2C399&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/uzbekistan-sees-foreign-investment-growth-of-over-60-per-cent-in-2024/ "Uzbekistan Sees Foreign Investment Growth of over 60 per cent in 2024") [Uzbekistan Sees Foreign Investment Growth of over 60 per cent in 2024](https://thailandbusinessnews.net/press-release/uzbekistan-sees-foreign-investment-growth-of-over-60-per-cent-in-2024/ "Uzbekistan Sees Foreign Investment Growth of over 60 per cent in 2024") - [![Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/connext-completes-enrollment-in-phase-2-trial-of-cnt201-in-dupuytrens-contracture/ "Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture") [Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture](https://thailandbusinessnews.net/press-release/connext-completes-enrollment-in-phase-2-trial-of-cnt201-in-dupuytrens-contracture/ "Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture") - [![Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/haiscos-class-1-innovative-drug-ciprocopan-succinate-tablets-approved-in-china-offering-a-new-treatment-option-for-patients-with-pnh/ "Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH") [Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH](https://thailandbusinessnews.net/press-release/haiscos-class-1-innovative-drug-ciprocopan-succinate-tablets-approved-in-china-offering-a-new-treatment-option-for-patients-with-pnh/ "Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/hi3d-v3-0-the-first-commercially-available-ai-3d-model-with-2048%c2%b3-voxel-resolution-launches-with-48-hours-of-free-access-for-everyone/) ## Hi3D V3.0, the First Commercially Available AI 3D Model with 2048³ Voxel Resolution, Launches with 48 Hours of Free Access for Everyone BEIJING, Aug. 19, 2026 /PRNewswire/ — Hi3D, the all-in-one AI 3D creation… [](https://thailandbusinessnews.net/press-release/testmu-ai-launches-agent-assurance-to-verify-ai-agents-before-they-ship/) ## TestMu AI Launches Agent Assurance to Verify AI Agents Before They Ship The new product verifies both the AI agents that talk to customers… [](https://thailandbusinessnews.net/press-release/engwe-previews-the-future-of-all-terrain-riding-with-the-upcoming-e26-3-0-dual-motor-atb/) ![ENGWE Previews the Future of All-Terrain Riding with the Upcoming E26 3.0 Dual-Motor ATB](https://i0.wp.com/mmx.prnasia.com/media/MS1970387/20260817030920EDT_image_1.jpg?resize=260%2C140&ssl=1 "ENGWE Previews the Future of All-Terrain Riding with the Upcoming E26 3.0 Dual-Motor ATB") ## ENGWE Previews the Future of All-Terrain Riding with the Upcoming E26 3.0 Dual-Motor ATB NEW YORK, Aug. 18, 2026 /PRNewswire/ — ENGWE is accelerating its U.S.… [](https://thailandbusinessnews.net/press-release/lg-energy-solution-announces-start-of-production-at-all-new-lansing-battery-plant/) ## LG Energy Solution Announces Start of Production at All-New Lansing Battery Plant The Lansing facility will build battery cells for both energy storage systems…